AST

Asterias Biotherapeutics Inc. Series A

AST

Delisted

AST was delisted on the 7th of March, 2019.

46 hedge funds and large institutions have $4.73M invested in Asterias Biotherapeutics Inc. Series A in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 15 closing their positions.

Upgrade to unlock

New

Increased

Maintained

Reduced

Closed

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

60% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 15

77% less call options, than puts

Call options by funds: $9K | Put options by funds: $39K

Holders

Holders Change

Holders Change %

% of All Funds

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

% of All Funds

New

Increased

Reduced

Closed

Calls

$9K

Puts

$39K

Net Calls

Net Calls Change

Top Buyers

1		+$599K
2		+$151K
3		+$20.7K
4	FCMT Founders Capital Management (Texas) Houston, Texas	+$4.15K
5	Simplex Trading Chicago, Illinois	+$1.91K

Top Sellers

1		-$841K
2		-$341K
3		-$305K
4	Goldman Sachs New York	-$75K
5	ECM Element Capital Management New York	-$74K

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–
46	46	–

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–
46	46	–

#	Name	Holding
26	26	–
27	27	–
28	28	–
29	29	–
30	30	–
31	31	–
32	32	–
33	33	–
34	34	–
35	35	–
36	36	–
37	37	–
38	38	–
39	39	–
40	40	–
41	41	–
42	42	–
43	43	–
44	44	–
45	45	–
46	46	–

Asterias Biotherapeutics Inc. Series A AST